Figure 4. Anti-androgen and Progestin Use in Male-to-Female Gender Reassignment Therapy

This table lists the most commonly used anti-androgen agents in cross-hormonal therapy. Note that spironolactone is the agent of choice in the United States. Although theoretically effective in blocking the action of testosterone, testosterone uptake inhibitors and growth hormone releasing antagonists are not commonly used.

[Close Window]